Kira Biotech Pty Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kira Biotech Pty Ltd - overview
Established
2019
Location
-, QLD, Australia
Primary Industry
Healthcare
About
Founded in 2019 and based in Brisbane, Australia, Kira Biotech Pty Ltd is a biotechnology company that develops immunomodulatory compounds for the treatment of immune system disorders. The company develops the product, KB312, an immune-cell depleting monoclonal antibody that targets activated immune cells and restores homeostasis through the induction of immune tolerance.
Current Investors
Longview Innovation , OneVentures, Queensland Government
Primary Industry
Healthcare
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Healthcare IT, Pharmaceutical Research & Development
Website
www.kirabiotech.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.